Skolkovo discussing prospects of regenerative medicine development

During the event, experts described the current state and prospects of the regenerative medicine development in Russia and in the world, discussed the potential of 3D bioprinting as one of the most effective technologies for the creation of organ prototypes and tissue replacement methods. The Director of medical programs of the Skolkovo Fund Helena Livshits told the journalists about the role of the innovation center in creating conditions for research in this industry: 

There is a transition from linear to exponential growth of knowledge and technologies in many areas of science. The same thing happens in regenerative medicine. Such technologies as bioprinting being at the intersection of biomedicine and IT become of particular importance. 

Experts attending the conference discussed the main directions of regenerative medicine development, as well as investment considerations in these projects. A special session within the conference was devoted to the three-dimensional printing technology. Speaking at the panel discussion, the scientific director of 3D Bioprinting Solutions Company Vladimir Mironov stressed the following: 

It's nice to see that the attention to 3D bioprinting has grown. This technology has a great future. Although it was included in the list of 200 promising technologies at the intersection of IT and medicine for the first time last year, we have been working on it for about 10 years. The most important task of our research is to build human organs suitable for implantation, and we use 3D bioprinting as a way to achieve this ambitious goal.

 

 

Source: chemrar.ru